Skip to main content
OpenTrials

Clinical trial condition

Diffuse Cutaneous Systemic Sclerosis

Explore clinical trials studying Diffuse Cutaneous Systemic Sclerosis. Study availability and eligibility vary by location and protocol.

20 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Cutaneous Systemic Sclerosis trial results

Recruiting

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

NCT07287670

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • EncompaSSc site in Phoenix, AZ Phoenix, Arizona, United States
  • EncompaSSc site in La Jolla, CA La Jolla, California, United States
  • EncompaSSc site in Loma Linda, CA Loma Linda, California, United States
  • University of California Los Angeles Scleroderma Center Los Angeles, California, United States
View all 58 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

NCT06470048

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Arizona Arthritis and Rheumatology Research PLLC Mesa, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Hoag Hospital Newport Beach, California, United States
  • Clinical Res Of W Florida Clearwater, Florida, United States
View all 128 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Recruiting

Controlling Hyperactive Immunity With Long-lived Lymphocytes

NCT07473154

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +13 more
Locations
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Guy's & St Thomas NHS Foundation Trust London, United Kingdom
  • Royal Free London NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

US Zamto-cel Autoimmune Diseases

NCT06708845

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +17 more
Locations
  • Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

NCT06375005

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Affiliated Hospital of Yangzhou University Yangzhou, Jiangsu, China
  • Huashan Hospital of Fudan University Shanghai, Shanghai Municipality, China
  • Hangzhou First People's Hospital Hangzhou, Zhejiang, China
  • Sir Run Run Shaw Hospital, Zhejiang University School Of Medicine Hangzhou, Zhejiang, China
View Trial Details

Related conditions